Zydus Lifesciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve unaudited financial results ....
ZYDUSLIFE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Zydus Lifesciences has informed the stock exchanges that its Board of Directors will meet on Tuesday, August 12, 2025. The main agenda item is to consider and approve the unaudited financial results for the quarter ended June 30, 2025 (Q1 FY26). The filing is made under SEBI's Listing Obligations and Disclosure Requirements (Regulation 29). The company's trading window for insiders has been closed and will reopen on Monday, August 18, 2025, after the results are announced. No financial numbers or details have been shared in this notice — it is purely a procedural intimation of an upcoming board meeting.
This is a standard pre-results announcement and does not contain any new business or financial information. Investors should watch for the actual Q1 FY26 results on August 12, 2025, which will be the first earnings update after the FY25 full-year results.